BMT CTN Protocol 0802

A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids with Mycophenolate Mofetil vs. Corticosteroids with Placebo as Initial Systemic Treatment of Acute GVHD

Below are protocol-related doucments, which may be periodically updated.

            Protocol Chair: Javier Bolanos-Meade, MD (410-614-3153)

            Protocol Co-Chair: Vincent T. Ho, MD (617-632-5938)

            Protocol Officer: Mary Horowitz, MD (414-805-0700)

            Protocol Coordinator: Kate Bickett (301-251-1161)

            Medical Monitor: Dianna Howard, MD ((859-323-1385)


The BMT CTN 0802 study closed to new patient accrual on November 14, 2011.